Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
Peptide antagonists of superantigen toxins
Raymond Kaempfer
*
*
Corresponding author for this work
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Contribution to journal
›
Article
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Peptide antagonists of superantigen toxins'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Peptide Antagonist
100%
Superantigen
100%
Toxic Shock
27%
Antagonist Peptide
18%
Shock
9%
Short Peptides
9%
Binding Site
9%
Tumor Necrosis Factor-α
9%
Unknown Function
9%
Large Families
9%
Complexity Classes
9%
Interleukin-2
9%
T Cell Activation
9%
Streptococcus Pyogenes (S. pyogenes)
9%
Human Immune System
9%
Immune Activation
9%
Interferon-γ
9%
Dodecamer
9%
Helix
9%
T Cell Receptor
9%
Histocompatibility
9%
Cellular Immune Response
9%
T Helper 1
9%
Antagonist Activity
9%
Toxic Actions
9%
Targeting Ligands
9%
Novel Domains
9%
Staphylococcus
9%
Gene Encoding
9%
Natural Mixture
9%
Approach to Design
9%
Human Peripheral Blood Mononuclear Cells (hPBMCs)
9%
Staphylococcal Enterotoxin B
9%
Pharmacology, Toxicology and Pharmaceutical Science
Superantigen
100%
Peptide
100%
Septic Shock
27%
Tumor Necrosis Factor
9%
Staphylococcus Aureus
9%
Cytokine
9%
Binding Site
9%
Interleukin 2
9%
T Lymphocyte Receptor
9%
Gamma Interferon
9%
Streptococcus pyogenes
9%
Staphylococcus Enterotoxin
9%
Bacterium
9%
Chemistry
Enterotoxin
12%
Tumor Necrosis Factor
12%
Biochemistry, Genetics and Molecular Biology
Histocompatibility Complex
12%